Surrozen, Inc.
Key Metrics
Market Snapshot
About
Surrozen, Inc. is a clinical-stage biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. The companys antibody-based therapeutics target tissue-specific disease processes across multiple organs including the eye, liver, intestine, and kidney. It aims to address diseases where Wnt pathway dysregulation plays a critical role.